Vascular endothelial growth factor and cellular chemotaxis: A possible autocrine pathway in adult T-cell leukemia cell invasion

Clinical Cancer Research

Volumn 7, Issue 9, 2001, Pages 2719-2726

  Hayashibara, T ^a   Yamada, Y ^a   Miyanishi, T ^a   Mori, H ^a   Joh, T ^a   Maeda, T ^a   Mori, N ^a   Maita, T ^a   Kamihira, S ^a   Tomonaga, M ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FMS LIKE TYROSINE KINASE 1; MESSENGER RNA; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOFLUOROMETRY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; T CELL LEUKEMIA;

ADULT; AUTOCRINE COMMUNICATION; CELL DIVISION; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, T-CELL; LYMPHOKINES; NEOPLASM INVASIVENESS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034813922     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Adult T-cell leukemia: Clinical and hematologic features of 16 cases
2. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma
3. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
4. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera
5. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease
6. Adult T cell leukaemia-lymphoma
7. A proposal for smoldering adult T-cell leukemia - Diversity in clinical pictures of adult T-cell leukemia
8. Clinical diversity in adult T-cell leukemia-lymphoma
9. Human T-lymphotropic virus type I in Japan
10. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection
11. What is the evidence that tumors are angiogenesis dependent?
12. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
13. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
14. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
15. The role of vascular endothelial growth factor in pathological angiogenesis
16. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
17. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
18. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
19. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
20. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
21. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR
22. Vascular permeability factor gene expression in normal and neoplastic human ovaries
23. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer
24. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
25. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
26. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
27. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels
28. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
29. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer
30. Cell migration: A physically integrated molecular process
31. Relationship of F-actin distribution to development of polar shape in human polymorphonuclear neutrophils
32. Roles of two VEGF receptors, Flt-1KDR, in the signal transduction of VEGF effects in human vascular endothelial cells
33. Vascular endothelial growth factor at high plasma levels is associated with extranodal involvement in adult T cell leukemia patients
34. Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: Expression of IL-15 receptor α on ATL cells
35. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome
36. Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocytemacrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival
37. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF
38. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells
39. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets
40. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
41. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
42. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt
43. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
44. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors
45. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
46. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF
47. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
48. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody
49. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization
50. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation
51. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration
52. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas